These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18302658)

  • 1. Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.
    Larsson G; Janson ET
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):200-4. PubMed ID: 18302658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
    Kölby L; Persson G; Franzén S; Ahrén B
    Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.
    Wisløff F; Gulbrandsen N; Hjorth M; Lenhoff S; Fayers P
    Eur J Haematol; 2005 Oct; 75(4):293-8. PubMed ID: 16146535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.
    Janson ET; Kauppinen HL; Oberg K
    Acta Oncol; 1993; 32(2):231-3. PubMed ID: 8323762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
    Bell D; Grimes D; Gurney H; Dalley D; Blackwell T; Fox R; Jeffery M
    Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
    Ahren B; Engman K; Lindblom A
    Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P; Kritikos K; Hatzopoulos A; Mitsibounas D
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
    Borg S; Glenngård AH; Osterborg A; Persson U
    Acta Oncol; 2008; 47(6):1009-17. PubMed ID: 18770060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPO in cancer anemia: benefits and potential risks.
    Milano M; Schneider M
    Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy.
    Iconomou G; Koutras A; Karaivazoglou K; Kalliolias GD; Assimakopoulos K; Argyriou AA; Ifanti A; Kalofonos HP
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):535-41. PubMed ID: 18707621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
    Covic A; Seica A; Gusbeth-Tatomir P; Goldsmith D
    J Nephrol; 2008; 21(4):478-84. PubMed ID: 18651536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
    Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.
    Christodoulou C; Dafni U; Aravantinos G; Koutras A; Samantas E; Karina M; Janinis J; Papakostas P; Skarlos D; Kalofonos HP; Fountzilas G
    Anticancer Res; 2009 Feb; 29(2):693-702. PubMed ID: 19331224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
    Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
    Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients.
    Puglisi F; Deroma L; Russo S; Cartenì G; Sporchia A; Ucci G; De Signoribus G; Del Prete S; Vecchione A; Pinotti G; Beccaglia P
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):175-82. PubMed ID: 18774730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-alpha.
    Talal AH; Weisz K; Hau T; Kreiswirth S; Dieterich DT
    Am J Gastroenterol; 2001 Sep; 96(9):2802-4. PubMed ID: 11569724
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
    Ahren B; Engman K; Lindblom A
    Anticancer Res; 1992; 12(3):881-4. PubMed ID: 1622146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.